M. Adorne

Variable temperature multiple light scattering analysis to determine the enthalpic term of a reversible agglomeration in submicrometric colloidal formulations: A quick quantitative comparison of the relative physical stability

S. Guterres, A. Pohlmann, P. Netz, 2013 .

Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan.

S. Guterres, A. Pohlmann, L. M. Colomé, 2012, International journal of pharmaceutics.

New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−)-functionalized nanocapsules

S. Guterres, A. Pohlmann, L. M. Colomé, 2014, Pharmaceutical Research.

Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules

J. S. Sousa, S. Guterres, A. Pohlmann, 2011 .

scFv-Anti-LDL(-)-Metal-Complex Multi-Wall Functionalized-Nanocapsules as a Promising Tool for the Prevention of Atherosclerosis Progression

B. Brüne, K. Araki, S. Guterres, 2021, Frontiers in Medicine.

Laronidase-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Promising Formulation for a More Effective Treatment of Mucopolysaccharidosis Type I

R. Giugliani, U. Matte, S. Guterres, 2015, Pharmaceutical Research.

Laronidase-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Promising Formulation for a More Effective Treatment of Mucopolysaccharidosis Type I

R. Giugliani, U. Matte, S. Guterres, 2014, Pharmaceutical Research.

New strategy to surface functionalization of polymeric nanoparticles: one-pot synthesis of scFv anti-LDL(−)-functionalized nanocapsules

S. Guterres, A. Pohlmann, L. M. Colomé, 2014, Pharmaceutical Research.

A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice.

M. Veras, P. Saldiva, A. Maranhão, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.